RNA-transfected dendritic cells in cancer immunotherapy

Journal of Clinical Investigation

Volumn 106, Issue 9, 2000, Pages 1065-1069

  Mitchell, D A ^a   Nair, S K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; VACCINE;

ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER IMMUNOTHERAPY; DENDRITIC CELL; DNA TRANSFECTION; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HALF LIFE TIME; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TARGET CELL; VACCINATION;

EID: 0033762762     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11405     Document Type: Review

References (31)

1. Proliferating dendritic cell progenitors in human blood
2. Dendritic cells and immune-based therapies
3. Shaping the repertoire of cytotoxic T lymphocyte responses: Explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens
4. In vivo detection of dendritic cell antigen presentation to CD4+ T cells
5. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses
6. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity
7. Vaccination of melanoma patients with peptideor tumor lysate-pulsed dendritic cells
8. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
9. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T-lymphocytes against tumor antigen in vivo
10. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
11. The makings of a tumor rejection antigen
12. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
13. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells
14. A comparison of gene transfer methods in human dendritic cells
15. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or 'self' antigens induce antitumor immunity in vivo
16. DNA-based immunization by in vivo transfection of dendritic cells
17. Exposing the immunology of naked DNA Vaccines
18. In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtk
19. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
20. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance
21. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
22. Multicomponent RNA plant virus infection derived from cloned viral cDNA
23. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors
24. Delivery of liposome-encapsulated RNA to cells expressing influenza virus hemagglutinin
25. Cationic liposome-mediated RNA transfection
26. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization
27. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
28. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA
29. RNA melanoma vaccine: Induction of antitumor immunity by human glycoprotein 100 mRNA immunization
30. Enhanced therapeutic efficacy of tumor RNApulsed dendritic cells after genetic modification with lymphotactin
31. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors